References
Pichichero ME: Recurrent and persistent otitis media. Pediatr Infect Dis J 2000, 19:911–916.
Babin E, Lemarchand V, Moreau S, et al.: Failure of antibiotic therapy in acute otitis media. J Laryngol Otol 2003, 117:173–176.
Dagan R: Clinical significance of resistant organisms in otitis media. Pediatr Infect Dis J 2000, 19:378–382.
Burkhardt JE, Walterspiel JN, Schaad UB: Quinolone arthropathy in animals versus children. Clin Infect Dis 1997, 25:1196–1204.
Jones RN, Pfaller MA: In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 2000, 31(Suppl 2):S16-S23.
Boswell FJ, Andrews J, Jevons G, Wise R: Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance. J Antimicrob Chemother 2002, 50:495–502.
Mandell LA, Peterson LR, Wise R, et al.: The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis 2002, 35:721–727.
Mandell LA, Bartlett JG, Dowell SF, et al.: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003, 37:1405–1433.
Resistance of Streptococcus pneumoniae to fluoroquinolones: United States, 1995–1999. MMWR Morb Mortal Wkly Rep 2001, 50:800–804.
Rights and permissions
About this article
Cite this article
Brook, I. Gatifloxacin therapy in otitis media in children. Curr Infect Dis Rep 7, 163–164 (2005). https://doi.org/10.1007/s11908-005-0028-7
Issue Date:
DOI: https://doi.org/10.1007/s11908-005-0028-7